Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Nicholls

Showing results (1301-1310 of 1,396) with videos related to

Pageof 140
Sort By:
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 15, 2022
Eukaryotic elongation factor 2 kinase regulates foam cell formation via translation of CD36Sanuja Fernando, Thalia Salagaras, Nisha Schwarz, et al.
Postgraduate Medical Journal|October 11, 2025
Healthcare workers' knowledge, attitudes, and practices towards cardiovascular disease prevention: a multi-national cross-sectional studyKylie J Q Heng, Shaun Seh Ern Loong, Jocelyn Han Shi Chew, et al.
The Medical Journal of Australia|August 1, 2020
Cardiovascular disease and COVID-19: Australian and New Zealand consensus statementSarah Zaman, Andrew I MacIsaac, Garry Lr Jennings, et al.
American Journal of Preventive Cardiology|July 30, 2021
Tackling cardiometabolic risk in the Asia Pacific regionJian-Jun Li, Khung Keong Yeo, Kathyrn Tan, et al.
Journal of the American Heart Association|November 15, 2024
Baseline Characteristics of Participants in STAREE: A Randomized Trial for Primary Prevention of Cardiovascular Disease Events and Prolongation of Disability-Free Survival in Older PeopleSophia Zoungas, Chris Moran, Andrea J Curtis, et al.
JACC. Cardiovascular Interventions|July 23, 2013
Detection by near-infrared spectroscopy of large lipid core plaques at culprit sites in patients with acute ST-segment elevation myocardial infarctionRyan D Madder, James A Goldstein, Sean P Madden, et al.
American Heart Journal|September 27, 2023
Comparison of tirzepatide and dulaglutide on major adverse cardiovascular events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: SURPASS-CVOT design and baseline characteristicsStephen J Nicholls, Deepak L Bhatt, John B Buse, et al.
American Heart Journal|May 9, 2022
Morphine and clinical outcomes in patients with ST segment elevation myocardial infarction treated with fibrinolytic and antiplatelet therapy: Insights from the TREAT trialWarren J Cantor, Mary Tan, Otavio Berwanger, et al.
Diabetes Care|April 6, 2026
Estimating the True MACE Benefits From Tirzepatide in SURPASS-CVOT Using an Imputed Placebo Analysis of REWINDNaveed Sattar, Hertzel C Gerstein, David D'Alessio, et al.
Haematologica|October 27, 2018
Chronic sympathetic driven hypertension promotes atherosclerosis by enhancing hematopoiesisAnnas Al-Sharea, Man K S Lee, Alexandra Whillas, et al.
Pageof 140

Showing results (1301-1310 of 1,396) with videos related to

Sort By:
Pageof 140
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 15, 2022
Eukaryotic elongation factor 2 kinase regulates foam cell formation via translation of CD36Sanuja Fernando, Thalia Salagaras, Nisha Schwarz, et al.
Postgraduate Medical Journal|October 11, 2025
Healthcare workers' knowledge, attitudes, and practices towards cardiovascular disease prevention: a multi-national cross-sectional studyKylie J Q Heng, Shaun Seh Ern Loong, Jocelyn Han Shi Chew, et al.
The Medical Journal of Australia|August 1, 2020
Cardiovascular disease and COVID-19: Australian and New Zealand consensus statementSarah Zaman, Andrew I MacIsaac, Garry Lr Jennings, et al.
American Journal of Preventive Cardiology|July 30, 2021
Tackling cardiometabolic risk in the Asia Pacific regionJian-Jun Li, Khung Keong Yeo, Kathyrn Tan, et al.
Journal of the American Heart Association|November 15, 2024
Baseline Characteristics of Participants in STAREE: A Randomized Trial for Primary Prevention of Cardiovascular Disease Events and Prolongation of Disability-Free Survival in Older PeopleSophia Zoungas, Chris Moran, Andrea J Curtis, et al.
JACC. Cardiovascular Interventions|July 23, 2013
Detection by near-infrared spectroscopy of large lipid core plaques at culprit sites in patients with acute ST-segment elevation myocardial infarctionRyan D Madder, James A Goldstein, Sean P Madden, et al.
American Heart Journal|September 27, 2023
Comparison of tirzepatide and dulaglutide on major adverse cardiovascular events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: SURPASS-CVOT design and baseline characteristicsStephen J Nicholls, Deepak L Bhatt, John B Buse, et al.
American Heart Journal|May 9, 2022
Morphine and clinical outcomes in patients with ST segment elevation myocardial infarction treated with fibrinolytic and antiplatelet therapy: Insights from the TREAT trialWarren J Cantor, Mary Tan, Otavio Berwanger, et al.
Diabetes Care|April 6, 2026
Estimating the True MACE Benefits From Tirzepatide in SURPASS-CVOT Using an Imputed Placebo Analysis of REWINDNaveed Sattar, Hertzel C Gerstein, David D'Alessio, et al.
Haematologica|October 27, 2018
Chronic sympathetic driven hypertension promotes atherosclerosis by enhancing hematopoiesisAnnas Al-Sharea, Man K S Lee, Alexandra Whillas, et al.
Pageof 140